However, for Q1 2025, Centene Corporation (NYSE:CNC) stated that premium and service revenues rose by 17% to $42.5 billion ...

Fintel reports that on July 16, 2025, B of A Securities downgraded their outlook for Centene (NYSE:CNC) from Neutral to ...

The Clayton-based health giant is likely to face increased challenges as federal government tightens Medicaid eligibility and ...

Shares of Centene are experiencing a historic collapse this week. Wednesday marked the worst single-day performance in the company's history.

Analysts have provided mixed ratings on Centene’s stock. Cantor Fitzgerald reiterated an Overweight rating with a $90 price target, citing limited impact from tightened Medicaid work requirements.

Investing.com -- Shares of Centene (NYSE:CNC) plunged more than 32% in premarket trading Wednesday after the company pulled its 2025 guidance, citing unexpectedly poor risk adjustment results in the ...

Investing.com -- Shares of Centene (NYSE:CNC) plunged more than 32% in premarket trading Wednesday after the company pulled its 2025 guidance, citing unexpectedly poor risk adjustment results in ...

Investing.com - JPMorgan downgraded Centene (NYSE:CNC), a $28.19 billion healthcare provider trading at 8.46x earnings, from Overweight to Neutral on Tuesday, slashing its price target to $48.00 ...

Meanwhile, Barclays downgraded Centene from Overweight to Equalweight, expressing concerns about the Part D and ACA segments and adjusting their earnings per share estimates downward for 2025 and ...

Centene's Fair Value Cut, Uncertainty Rating Downgraded on Individual Plan and Medicaid Headwinds Julie Utterback Jul 2, 2025 Share ...